Comparing the miRNAs and traditional tumor markers in serum samples from patients with seminomatous and non-seminomatous TGCTs indicated that AFP (p < 0.001) and β-HCG (p = 0.004) were aberrant (increased) in non-seminoma patients. Here, AFP is linked to neoplasm.